Aging
Navigate
Submit an Article
Research Paper|Volume 15, Issue 18|pp. 9633–9660
A novel risk model of three gefitinib-related genes FBP1, SBK1 and AURKA is related to the immune microenvironment and is predicting prognosis of lung adenocarcinoma patients
Back to articleFigure 1(1 of 13)
100%
Figure 1
Figure 1.Gefitinib could inhibit cancer cell growth and migration. (A–C) Cell viability; (D) Cell apoptosis; (E) Cell Migration; (F) Cell Invasion.